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Background
Among all hereditary cancer syndromes MEN Type
1 and 2 are characterized by the concurrent but inde-
pendent appearance of benign as well as malignant
tumours. Neoplasias of parathyroid glands, pancreas,
pituitary gland as well as neuroendocrine tumours of
the stomach and intestinal wall are typical for MEN 1.
Medullary thyroid carcinomas together with parathyroid
adenomas and phaeochromocytomas are hallmarks of
MEN 2. This presentation gives an overview about the
multitude of imaging techniques that are inevitable for
diagnostics and long-term follow up in MEN patients
beyond molecular genetic and laboratory methods.
Methods
Ultrasound (US) combined with nuclear medicine tech-
niques are the leading methods to screen for pathologies
of thyroid, parathyroid glands and cervical lymph nodes.
For assessing metastases of a medullary thyroid carci-
noma (MEN 2) DOTA-PET/CT is useful in addition to
a CT/MR scan and neck and abdominal US. To detect
phaeochromocytoma in MEN 2, CT and MRI are super-
ior to US. MIBG scintigraphy can be performed in
unclear cases. In primary hyperparathyroidism in MEN
1 cervical US is the leading method, supplemented
by Tc-99m sestamibi scintigraphy or 11c-methionine
PET/CT. DOTATOC PET/CT may supplement contrast-
enhanced CT or MRI in detecting even small gastrinomas
or other neuroendocrine tumours of the GI tract. In the
examination of the pituitary gland, gadolinium enhanced
dynamic MRI is standard.
Conclusion
Given the complexity of multimodal imaging, a close
collaboration of clinical radiology and nuclear medicine
is essential to tailor the imaging protocol for MEN
patients.
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